Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Slade, US

Alexander M. Slade, Hollywood Hills, CA US

Patent application numberDescriptionPublished
20120279551METHOD OF IMPROVING THE EFFICIENCY OF LOOSELY PACKED SOLAR CELLS IN DENSE ARRAY APPLICATIONS - An increased efficiency Concentrator Photovoltaic System having a plurality of solar cells laterally spaced from each other on a substrate panel. The solar cells are mounted on metal traces that support the cells and provide a path for the electrical output of the individual cells. Ribbons or wires, which provide a connection between the front contact of the solar cells to the appropriate metal traces form a circuit connecting the cells in desired configurations, Intercellular areas are provided between the lateral edges of the respective solar cells. A plurality of tubular enclosures are mounted directly above the solar cells. The top edge of the tubular enclosures have a circumference greater than the circumference of the bottom edges of the tubular enclosures. The inner surfaces of the tubular enclosure walls are reflective and direct solar rays to the respective solar cells thereby increasing the efficiency of the Photovoltaic system.11-08-2012

Ann J. Slade, Bellevue, WA US

Patent application numberDescriptionPublished
20100196582SOYBEANS WITH REDUCED ISOFLAVONES - Non-naturally occurring soybean plants and seeds having reduced isoflavones are provided. A series of independent non-transgenic human-induced mutations found in one or more isoflavone synthase genes of soybean; soybean plants having these mutations in one or more isoflavone synthase genes; and a method of creating and finding similar and/or additional mutations of the isoflavone synthase gene by screening pooled and/or individual DNA of soybean plants. The results are soybean plants and seeds having reduced isoflavones.08-05-2010
20110113507Tomatoes That Soften More Slowly Post-Harvest Due To Non-Transgenic Alterations In An Expansin Gene - A series of independent human-induced non-transgenic mutations found in an expansin gene (LeExp1) of tomato; tomato plants having these mutations in their LeExp1 genes; and a method of creating and identifying similar and/or additional mutations in the LeExp1 gene by screening pooled and/or individual tomato plants. The tomato plants of the present invention exhibit fruit that soften more slowly post-harvest without having the inclusion of foreign nucleic acids in their genomes.05-12-2011

Ann J. Slade, Kenmore, WA US

Patent application numberDescriptionPublished
20090280234Tomatoes Having Reduced Polygalacturonase Activity Caused by Non-Transgenic Mutations in the Polygalacturonase Gene - A series of independent non-transgenic mutations found in the fruit PG gene of tomato; tomato plants having these mutations in their fruit PG gene; and a method of creating and identifying similar and/or additional mutations in the PG gene by screening pooled and/or individual tomato plants. The tomato plants of the present invention exhibit reduced PG enzyme activity and fruit that soften more slowly post harvest without having the inclusion of foreign nucleic acids in their genomes.11-12-2009

Patent applications by Ann J. Slade, Kenmore, WA US

Ann Joan Slade, Kenmore, WA US

Patent application numberDescriptionPublished
20110004965COMPOSITIONS AND METHODS FOR MODULATION OF PLANT CELL DIVISION - The present invention provides compositions and methods for modulating cell division in plants. In particular, the present invention provides polynucleotides that encode REVOLUTA. In addition, REVOLUTA vectors and transformed plants are provided wherein plant cell division is modulated by expression of a REVOLUTA transgene as compared to a control population of untransformed plants. The present invention also provides methods for the isolation and identification of REVOLUTA genes from higher plants.01-06-2011
20120079628COMPOSITIONS AND METHODS FOR MODULATION OF PLANT CELL DIVISION - The present invention provides compositions and methods for modulating cell division in plants. In particular, the present invention provides polynucleotides that encode REVOLUTA. In addition, REVOLUTA vectors and transformed plants are provided wherein plant cell division is modulated by expression of a REVOLUTA transgene as compared to a control population of untransformed plants. The present invention also provides methods for the isolation and identification of REVOLUTA genes from higher plants.03-29-2012

Patent applications by Ann Joan Slade, Kenmore, WA US

Anthony P. Slade, St. Ann, MO US

Patent application numberDescriptionPublished
20100043618CUTTING TOOL - A method and apparatus for a cutting tool system. In one advantageous embodiment, an apparatus may comprise a carriage that is movable along an axis, a cutting tool, and a depth controller. The cutting tool may be capable of being removably attached to the carriage. The depth controller may be capable of controlling a cutting depth of the cutting tool with respect to a surface of a workpiece closest to a part.02-25-2010
20100054883CHAMFER TOOL - An apparatus may comprise a body, a pilot, a blade, a shaft, and a guide. The body may have a first end and a second end. The pilot may extend from the first end of the body and the blade may be attached to the body and positioned longitudinally on the body at the first end. The shaft may extend from the second end of the body, and the guide may be capable of receiving the pilot.03-04-2010
20110002751GUIDE ASSEMBLY AND METHOD - A guide assembly comprises a frame assembly, a plurality of clamping assemblies, and a head assembly. The clamping assemblies may be mountable to the frame assembly for attaching the frame assembly to a structure. The head assembly may be mountable to the frame assembly and may include a tool coupled to the head assembly. The tool assembly may be axially movable relative to the head assembly to cause the tool to exert a down force on the structure when the frame assembly is attached thereto.01-06-2011

Boyd E. Slade, Austin, TX US

Patent application numberDescriptionPublished
20090195379ENVIRONMENTAL MONITORING DEVICE - The disclosure is directed to a sensor device including processing circuitry, at least one sensor coupled to the processing circuitry, a serial data interface coupled to the processing circuitry and memory responsive to the processing circuitry. The memory includes a static unique identification number. The serial data interface provides access to retrieve the static unique identification number and sensed data measured with the at least one sensor from the memory.08-06-2009

Charles S. Slade, Springfield, AZ US

Patent application numberDescriptionPublished
20100316977COUNTERMEASURE DEVELOPMENT METHOD AND SYSTEM - An architecture is provided for incorporating systems-thinking and cognitive psychology. A simulation nodule partners with a systemizing nodule to develop a solution (a countermeasure) a problem that an opponent could apply to injure the entity. Problem-defining, solution-developing, weakness-exposing, and/or solution-revising steps can be conceptualized from the opponent's viewpoint thanks to a role-reversing nodule, defensive theories can be tested by a combat-imitating nodule, and conclusions can be confirmed via a reality-checking nodule.12-16-2010

David E. Slade, Portage, MI US

Patent application numberDescriptionPublished
20100273238Cellular Permissivity Factor for Viruses and Uses Thereof - The present invention provides methods and compositions related to the generation of host cells permissive for virus growth, particularly Porcine Reproductive and Respiratory Syndrome (PRRS) virus.10-28-2010
20120015425Cellular Permissivity Factor for Viruses and Uses Thereof - The present invention provides methods and compositions related to the generation of host cells permissive for virus growth, particularly Porcine Reproductive and Respiratory Syndrome (PRRS) virus.01-19-2012

Patent applications by David E. Slade, Portage, MI US

David J. Slade, Durham, NC US

Patent application numberDescriptionPublished
20080214614CYTOSKELETAL ACTIVE RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE - The present invention is directed to synthetic cytoskeletal active compounds that are inhibitors of rho-associated protein kinase. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carrier. The invention is additionally directed to a method of preventing or treating diseases or conditions associated with cytoskeletal reorganization. In one embodiment of the invention, the method treats increased intraocular pressure, such as primary open-angle glaucoma. The method comprises administering to a subject a therapeutically effective amount of a cytoskeletal active compound of Formula I or Formula II, wherein said amount is effective to influence the actomyosin interactions, for example by leading to cellular relaxation and alterations in cell-substratum adhesions.09-04-2008
20100130572CYTOSKELETAL ACTIVE COMPOUNDS, COMPOSITION AND USE - The present invention is directed to synthetic cytoskeletal active compounds that are related to natural Latrunculin A or Latrunculin B. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carrier. The invention is additionally directed to a method of preventing or treating diseases or conditions associated with actin polymerization. In one embodiment of the invention, the method treats increased intraocular pressure, such as primary open-angle glaucoma. The method comprises administering to a subject a therapeutically effective amount of a cytoskeletal active compound of Formula I or II, wherein said amount is effective to influence the cytoskeleton, for example by inhibiting actin polymerization.05-27-2010
20120046275CYTOSKELETAL ACTIVE RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE - The present invention is directed to synthetic cytoskeletal active compounds that are inhibitors of rho-associated protein kinase. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carrier. The invention is additionally directed to a method of preventing or treating diseases or conditions associated with cytoskeletal reorganization. In one embodiment of the invention, the method treats increased intraocular pressure, such as primary open-angle glaucoma. The method comprises administering to a subject a therapeutically effective amount of a cytoskeletal active compound of Formula I or Formula II, wherein said amount is effective to influence the actomyosin interactions, for example by leading to cellular relaxation and alterations in cell-substratum adhesions.02-23-2012

Patent applications by David J. Slade, Durham, NC US

David J. Slade, Claremont, CA US

Patent application numberDescriptionPublished
20100022775PROCESS FOR THE PREPARATION OF RHO-KINASE INHIBITOR COMPOUNDS - The present invention is directed to practical high-yielding synthetic processes to prepare compounds of general Formula III, IV, V, VII, VIII, IX, X, XII, XIV, and XV. Such compounds are useful as final products or can be used as intermediates and be further modified to prepare other desired products such as rho-kinase inhibitors. The present invention is also directed to certain novel compounds and/or novel solid forms of certain compounds.01-28-2010
20110144150BRIDGED BICYCLIC RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE - The present invention is directed to synthetic bridged bicyclic compounds that are inhibitors of rho-associated protein kinase. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carrier. The invention is additionally directed to a method of preventing or treating diseases or conditions associated with cytoskeletal reorganization. The method comprises administering to a subject a therapeutically effective amount of a Rho kinase inhibitory compound of Formula I, wherein said amount is effective to influence the actomyosin interactions, for example, by leading to cellular relaxation and alterations in cell-substratum adhesions. In one embodiment, the method treats increased intraocular pressure, such as primary open-angle glaucoma. In another embodiment, the method treats diseases or conditions of the lung associated with excessive cell proliferation, remodeling, inflammation, vasoconstriction, bronchoconstriction, airway hyperreactivity and edema.06-16-2011

Edward Clay Slade, North Logan, UT US

Patent application numberDescriptionPublished
20090199972WATER EVAPORATION SYSTEM AND METHOD - A fluid evaporation system includes a housing bounding a fluid reservoir and an air flow path that is disposed over top of the fluid reservoir. The housing has an inlet opening and a spaced apart outlet opening that both provide communication between the outside environment and the air flow path. A fan is positioned to draw the air out of the air flow path through the outlet opening. A baffle projects into the air flow path at a location between inlet opening and the outlet opening so as to constrict the area of the air flow path thereat. A plurality of spray nozzles are positioned within air flow path between the baffle and the first end of the housing. A pump is configured to draw fluid from the reservoir and deliver it to the plurality of spray nozzles.08-13-2009
20110139378WASTEWATER TREATMENT SYSTEMS AND METHODS - A fluid evaporation system includes a housing bounding a fluid reservoir and an air flow path that is disposed over top of the fluid reservoir. The housing has an inlet opening and a spaced apart outlet opening that both provide communication between the outside environment and the air flow path. A blower is positioned to draw the air into the air flow path and force the air through the outlet opening. A misting system positioned within the air flow path increases the water content of the air stream. A demister is positioned upstream from the outlet opening and downstream from the misting system.06-16-2011
20110140457WASTEWATER PRE-TREATMENT AND EVAPORATION SYSTEM - A fluid evaporation system includes a housing bounding an airflow path. A misting system is positioned within the airflow path for spraying a wastewater into the airflow path. Water in the misted wastewater is evaporated, thereby concentrating minerals in the wastewater. A pretreatment system is positioned upstream from the fluid evaporator. The pretreatment system includes a gas induced separator. Separation of hydrocarbons and water are enhanced using a polymer and/or by lowering the pH of the wastewater.06-16-2011

G. Kiniski Slade, Mt. Vernon, NY US

Patent application numberDescriptionPublished
20100230368Display stand - A display stand for displaying hats having a plurality of rotatable sections which rotate about a central support wherein each section may comprise a plurality of downwardly sloped trays wherein the central support is fixed to a surrounding structure which is enclosed by panels and a door which may be lockable.09-16-2010

Herbert B. Slade, Woodbury, MN US

Patent application numberDescriptionPublished
20080280943METHODS AND PACKAGES TO ENHANCE SAFETY WHEN USING IMIQUIMOD TO TREAT CHILDREN DIAGNOSED WITH SKIN DISORDERS - Pharmaceutical packages and methods for enhancing the safety of imiquimod when used to treat children affected by skin disorders are disclosed. More particularly, the safety profile of imiquimod use is enhanced by providing information to the children, guardians of the children, including parents and health care professionals, that systemic absorption of imiquimod and other effects may be observed when imiquimod therapy is used to treat children of between about 2 and about 12 years of age. Examples of systemic absorption include a serum imiquimod concentrations of less than about 2 ng/mL, a decrease in median white blood cell count by about 1.4*1011-13-2008

Jeremiah Slade, Shirley, MA US

Patent application numberDescriptionPublished
20100280581Patient warming applique - A patient warming appliqué typically includes a cover layer, a tape layer for releasably securing the appliqué to the patient's skin and an array of encapsulated cells. The encapsulated cells include a chemical heating mechanism beneath the cover layer and a phase change gel sheet between the chemical heating mechanism and the tape layer. The phase change gel sheet is configured to melt and flow when the chemical heating mechanism is activated. The preferred appliqué further includes zones of weakness between the spaced cells allowing the individual cells or a subset of cells to be removed from the appliqué.11-04-2010
20120030935Electrically active textiles, articles made therefrom, and associated methods - A method of making articles from electrically active textiles. First and second fabric pieces include conductors therein. A seam is established between the first and second fabric pieces. A determination is made, at the seam, based on one or more predetermined factors, which conductors of the first fabric piece intersect or overlap with which conductors of the second fabric piece. At the seam, an electrical and mechanical connection is formed between select conductors of the first fabric piece and select conductors of the second fabric piece.02-09-2012

John Slade, West Hollywood, CA US

Patent application numberDescriptionPublished
20120143921SYSTEMS AND METHODS FOR MANAGING SOCIAL NETWORKS BASED UPON PREDETERMINED OBJECTIVES - Relationship management systems in accordance with embodiments of the invention are configured to provide systematic ways for a user to measure, and manage relationships in the user's social network. One embodiment of the invention includes a relationship management server system, and a database. In addition, the relationship management server system is configured to store a user account associated with a user in the database, store information concerning contacts associated with the user in the database, store event information associated with the user and at least one of the stored contacts in the database, store at least one objective in the database, score at least one relationship between the user and a contact based upon stored event information associated with the user and the contact to create a scored relationship graph, and generate a recommendation concerning an action based upon the stored objective and the scored relationship graph.06-07-2012

John Slade, Wake Forest, NC US

Patent application numberDescriptionPublished
20090136636PREPARATION OF AN EDIBLE PRODUCT FROM DOUGH - The present invention is directed to mold control and extended shelf life methods and compositions for preparing edible dough-based products, such as, for example, breads, by treating the surface of the dough used to prepare the edible product with at least one preservative and at least one pH adjusting agent prior to or during baking. The present invention is also directed to methods and compositions for preparing edible dough-based products, such as, for example, breads, by treating the surface of the dough used to prepare the edible product with a at least one pH adjusting agent prior to or during baking. The present invention is further directed to improved pan oil compositions for preparing edible dough based products which comprise at least one preservative in an amount effective to inhibit mold growth on the surface of the bread prepared from the dough and at least one pH adjusting agent in an amount effective to improve the activity of the at least one preservative and/or inhibit microbial growth on the surface of the bread prepared from the dough.05-28-2009
20090204552PREPARATION OF AN EDIBLE PRODUCT FROM DOUGH - The present invention is directed to mold control and extended shelf life methods and compositions for preparing edible dough-based products, such as, for example, breads, by treating the surface of the dough used to prepare the edible product with at least one preservative and at least one pH adjusting agent prior to or during baking. The present invention is also directed to methods and compositions for preparing edible dough-based products, such as, for example, breads, by treating the surface of the dough used to prepare the edible product with a at least one pH adjusting agent prior to or during baking. The present invention is further directed to improved pan oil compositions for preparing edible dough based products which comprise at least one preservative in an amount effective to inhibit mold growth on the surface of the bread prepared from the dough and at least one pH adjusting agent in an amount effective to improve the activity of the at least one preservative and/or inhibit microbial growth on the surface of the bread prepared from the dough.08-13-2009
20090214732PREPARATION OF AN EDIBLE PRODUCT FROM DOUGH - The present invention is directed to mold control and extended shelf life methods and compositions for preparing edible dough-based products comprising (a) treating a surface of a dough with (i) at least one preservative in an amount effective to inhibit mold growth on the surface of bread prepared from the dough, wherein the at least one preservative is suspended in the composition in the form of very fine preservative particles having a mean particle size below 30 μm and (ii) at least one pH adjusting agent in an amount effective to improve the activity of the at least one preservative and/or inhibit microbial growth on the surface of bread prepared from the dough; and (b) baking the dough to form the bread; wherein the treating is done prior to or during baking.08-27-2009
20110244096PREPARATION OF AN EDIBLE PRODUCT FROM DOUGH - The present invention is directed to mold control and extended shelf life methods and compositions for preparing edible dough-based products, such as, for example, breads, by treating the surface of the dough used to prepare the edible product with at least one preservative and at least one pH adjusting agent prior to or during baking. The present invention is also directed to methods and compositions for preparing edible dough-based products, such as, for example, breads, by treating the surface of the dough used to prepare the edible product with a at least one pH adjusting agent prior to or during baking. The present invention is further directed to improved pan oil compositions for preparing edible dough based products which comprise at least one preservative in an amount effective to inhibit mold growth on the surface of the bread prepared from the dough and at least one pH adjusting agent in an amount effective to improve the activity of the at least one preservative and/or inhibit microbial growth on the surface of the bread prepared from the dough.10-06-2011

Patent applications by John Slade, Wake Forest, NC US

Jonathan E. Slade, Fenton, MI US

Patent application numberDescriptionPublished
20080211155Spring damper - A damper is shown for damping the movements of a valve spring in an engine. The valve spring can be housed within the damper or the damper may be located inside of the valve spring. The damper is made from a suitable polymer and has one or more slots located radially to a central axis and one or more rings or bands. The rings or bands are located on the outer surface of the damper where the valve spring is located within the damper. The rings or bands are located on the inner surface of the damper where the valve spring surrounds the damper. The cross section, number and location of the slots, rings or bands can be adjusted depending on the particular application of the damper and the amount of damping that is desired for the particular application.09-04-2008
20080211156Spring damper - A damper is shown for damping the movements of a valve spring in an engine. The valve spring can be housed within the damper or the damper may be located inside of the valve spring. The damper is made from a suitable polymer and has one or more tabs or slots located radially to a central axis and one or more helical springs, rings or bands housed in the slots or between the tabs. The helical springs, rings or bands are located on the outer surface of the damper where the valve spring is housed within the damper. The cross section, number and location of the tabs, slots, helical springs, rings or bands can be adjusted depending on the particular application of the damper and the amount of damping that is desired for the particular application. The damper can also incorporate a hub or stem seal.09-04-2008
20110259689Spring damper - A damper is shown for damping the movements of a valve spring in an engine. The valve spring can be housed within the damper or the damper may be located inside of the valve spring. The damper is made from a suitable polymer and has one or more tabs or slots located radially to a central axis and one or more helical springs, rings or bands housed in the slots or between the tabs. The helical springs, rings or bands are located on the outer surface of the damper where the valve spring is housed within the damper. The cross section, number and location of the tabs, slots, helical springs, rings or bands can be adjusted depending on the particular application of the damper and the amount of damping that is desired for the particular application. The damper can also incorporate a hub or stem seal and ports for receiving oil.10-27-2011

Rachel Slade, Salt Lake City, UT US

Patent application numberDescriptionPublished
20080249135COMPOUNDS FOR ALZHEIMER'S DISEASE - The invention provides novel compounds useful for the treatment of neurodegenerative disorders including Alzheimer's disease and dementia. The compounds have a substituents chosen from -L-C(═O)OH, -L-CH═CHC(═O)OH, -L-C(═O)NH10-09-2008
20100184975COMPOUNDS FOR ALZHEIMBER'S DISEASE - The invention provides novel compounds useful for the treatment of neurodegenerative disorders including Alzheimer's disease and dementia. The compounds have a substituents chosen from -L-C(═O)OH, -L-CH═CHC(═O)OH, -L-C(═O)NH07-22-2010
20120225873COMPOUNDS FOR ALZHEIMER'S DISEASE - The invention provides novel compounds useful for the treatment of neurodegenerative disorders including Alzheimer's disease and dementia. The compounds have a substituents chosen from -L-C(═O)OH, -L-CH═CHC(═O)OH, -L-C(═O)NH09-06-2012

Patent applications by Rachel Slade, Salt Lake City, UT US

Rachel M. Slade, Salt Lake City, UT US

Patent application numberDescriptionPublished
20080249158PYRROLE DERIVATIVES AS THERAPEUTIC COMPOUNDS - Novel pyrrole derivatives are disclosed as Aβ10-09-2008
20090155903PHARMACEUTICAL COMPOSITION AND METHOD - The invention provides compounds, pharmaceutical compositions and methods for the therapeutic treatment and prevention of neurodegenerative disorder and other Aβ06-18-2009
20100216862Pyrrole Derivatives As Therapeutic Compounds - Novel pyrrole derivatives are disclosed as Aβ08-26-2010

Patent applications by Rachel M. Slade, Salt Lake City, UT US

Richard Slade, Austin, TX US

Patent application numberDescriptionPublished
20080301242SYSTEM AND METHOD FOR PROTECTING CHAT CONTENT - Provided is a method for ensuring the privacy of communication during a computer chat session. The claimed subject matter enables each participant of a chat session to choose whether or not to allow other participants to save, print or archive the text of the session. At the beginning of or during a chat session, a particular participant decides that the chat session should be private. The participant transmits a message indicating the desire to make the chat session private. Each participant receives a pop-up message that communicates the privacy request and is provided the option of accepting or declining the request. If a sufficient number of participants accept the request, programming logic that blocks any attempt to save the chat content to memory is executed with respect to the chat session. Different chat sessions may be configured with different options such as, but not limited to, inclusive and non-inclusive.12-04-2008

Scott Richard Slade, Livonia, MI US

Patent application numberDescriptionPublished
20120111138High Load Resistant Stop Lamp Switch Brackets and Brake Pedal Assemblies Incorporating the Same - A switch bracket includes a bracket body that includes a lower surface and a kickplate. The switch bracket also includes a switch mount located on the lower surface of the bracket body, where at least a portion of the kickplate extends outward from the lower surface further than the stop lamp switch that is retained at the switch mount. In another embodiment, a brake pedal assembly includes a switch bracket coupled to a pedal mount, the switch bracket having a lower surface and a kickplate. The brake pedal assembly also includes a stop lamp switch coupled to the lower surface of the switch bracket, and a brake pedal rotationally engaged with the pedal mount and coupled to the stop lamp switch.05-10-2012

Sean Slade, Detroit, MI US

Patent application numberDescriptionPublished
20120204832SYSTEMS AND METHODS FOR DECREASING TORQUE FLUCTUATIONS DURING CYLINDER DEACTIVATION AND REACTIVATION - A control system for an engine includes a first spark control module and a second spark control module. The first spark control module retards spark timing for M of N cylinders of the engine to a first spark timing during a period before deactivating or after reactivating the M cylinders, wherein M is an integer greater than or equal to one, and wherein N is an integer greater than M. The second spark control module advances spark timing for (N−M) active cylinders of the engine to a second desired spark timing during the period before deactivating or after reactivating the M cylinders, wherein the second spark timing is greater than the first spark timing.08-16-2012

Stephen Slade, Houston, TX US

Patent application numberDescriptionPublished
20090171326Medical Device and Method - A medical device comprising a lens epithelial cell deactivation unit adapted for selectively deactivating lens epithelial cells of an eye.07-02-2009

Tom B. Slade, Denton, TX US

Patent application numberDescriptionPublished
20120117016AUTONOMOUS INTELLIGENT CONTENT ITEMS - One embodiment of the disclosure provides a storage unit of digitally encoded information stored on a non-transitory storage medium. The storage unit can be referred to as an intelligent content item. The intelligent content item can include an intelligent wrapper, content data, and intelligent functions. The intelligent wrapper can enable the intelligent content item to function as a self-managing unit of storage. The content data can be contained within the intelligent wrapper. The intelligent functions can be contained within the intelligent wrapper. The intelligent functions can represent abilities of the intelligent wrapper to autonomously and dynamically manage a state of the intelligent content item and manage specifics for content consumers to access and utilize the content data.05-10-2012